Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Mitchell F Brin, Charmaine James & John Maltman. (2014) Botulinum toxin type A products are not interchangeable: a review of the evidence. Biologics: Targets and Therapy 8, pages 227-241.
Read now
Read now
Jae Hyung Lee, Ji Ho Park, Soo Keun Lee, Kwang Ho Han, Sang Duck Kim, Chun Sik Yoon, Jae Young Park, Joo Heung Lee, Jun Mo Yang & Jong Hee Lee. (2014) Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A. Journal of Dermatological Treatment 25:4, pages 326-330.
Read now
Read now
Andy Pickett. (2011) Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data. Clinical Ophthalmology 5, pages 1287-1290.
Read now
Read now
Juwan Park, Michael S Lee & Andrew R Harrison. (2011) Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clinical Ophthalmology 5, pages 725-732.
Read now
Read now
Andy Pickett & Raymond L. Rosales. (2011) New Trends in the Science of Botulinum Toxin-A as Applied in Dystonia. International Journal of Neuroscience 121:sup1, pages 22-34.
Read now
Read now
Jürgen Frevert & Dirk Dressler. (2010) Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?. Biologics: Targets and Therapy 4, pages 325-332.
Read now
Read now
Koenraad de Boulle & Ada Trindade de Almeida. (2010) Addressing recent concerns in comparative studies of botulinum toxin type A. Journal of Cosmetic and Laser Therapy 12:5, pages 246-248.
Read now
Read now
Alberto Goldman & Uwe Wollina. (2010) Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures. Clinical Interventions in Aging 5, pages 293-299.
Read now
Read now
Mitchell F. Brin, Kelvin Tan & Conor Gallagher. (2009) Differences in botulinum toxins: Time to end the confusion. Journal of Cosmetic and Laser Therapy 11:3, pages 180-181.
Read now
Read now
Andy Pickett & Berthold Rzany. (2009) Botulinum toxin in aesthetic applications: ‘How often misused words generate misleading thoughts’. Journal of Cosmetic and Laser Therapy 11:3, pages 178-179.
Read now
Read now
Articles from other publishers (15)
Nicholas Ketchum, Stefano Carda, Michael W O'Dell, Patrik Säterö, Jorge Jacinto, Thierry Deltombe & Gerard E. Francisco. (2022) Module 4. The Journal of the International Society of Physical and Rehabilitation Medicine 5:Suppl 1, pages S50-S60.
Crossref
Crossref
A.A. Sharova. (2021) Pharmacokinetic characteristics of botulinum toxin type A. Plasticheskaya khirurgiya i esteticheskaya meditsina:1, pages 67.
Crossref
Crossref
Hermine Warren, Kim Welch & Sarah Coquis-Knezek. (2020) AbobotulinumtoxinA for Facial Rejuvenation: What Affects the Duration of Efficacy?. Plastic Surgical Nursing 40:1, pages 37-44.
Crossref
Crossref
Dirk Dressler, Lizhen Pan, Fereshte Adib Saberi & Hans Bigalke. (2019) Do complexing proteins provide mechanical protection for botulinum neurotoxins?. Journal of Neural Transmission 126:8, pages 1047-1050.
Crossref
Crossref
Jon D. Perenack & Shelly Williamson-Esnard. 2019. Neurotoxins and Fillers in Facial Esthetic Surgery. Neurotoxins and Fillers in Facial Esthetic Surgery
19
45
.
Anna Baker. (2017) Injectors should prioritise accuracy when performing botulinum toxin treatments. Journal of Aesthetic Nursing 6:8, pages 414-416.
Crossref
Crossref
Murad Alam, Hayes B. Gladstone & David M. Ozog. 2017. Botulinum Toxins. Botulinum Toxins
109
119
.
Julie Bass Kaplan. (2016) The Dilution Confusion. Plastic Surgical Nursing 36:1, pages 24-27.
Crossref
Crossref
Foad Nahai, Z. Paul Lorenc, Jeffrey M. Kenkel, Steven Fagien, Haideh Hirmand, Mark S. Nestor, Anthony P. Sclafani, Jonathan M. Sykes & Heidi A. Waldorf. (2013) IncobotulinumtoxinA (Xeomin). Aesthetic Surgery Journal 33:1_Supplement, pages 18S-22S.
Crossref
Crossref
Corey Maas, Michael A. C. Kane, Vivian W. Bucay, Shawn Allen, David J. Applebaum, Leslie Baumann, Sue Ellen Cox, Julius W. Few, John H. Joseph, Z. Paul Lorenc, Amir Moradi, Mark S. Nestor, Joel Schlessinger, Mitchell Wortzman, Ira Lawrence, Xiaoming Lin & Diane Nelson. (2012) Current Aesthetic Use of AbobotulinumtoxinA in Clinical Practice: An Evidence-Based Consensus Review. Aesthetic Surgery Journal 32:1_Supplement, pages 8S-29S.
Crossref
Crossref
Doris Hexsel, Cristiano Brum, Débora Zechmeister do Prado, Mariana Soirefmann, Francisco Telechea Rotta, Taciana Dal’Forno & Ticiana C. Rodrigues. (2012) Field effect of two commercial preparations of botulinum toxin type A: A prospective, double-blind, randomized clinical trial. Journal of the American Academy of Dermatology 67:2, pages 226-232.
Crossref
Crossref
Berthold Rzany & Alexander Nast. 2012. Evidence-Based Procedural Dermatology. Evidence-Based Procedural Dermatology
333
342
.
Andy Pickett. (2012) Consistent Biochemical Data are Essential for Comparability of Botulinum Toxin Type A Products. Drugs in R&D 11:1, pages 97-98.
Crossref
Crossref
Bernard Rossi. 2010. Office-Based Cosmetic Procedures and Techniques. Office-Based Cosmetic Procedures and Techniques
166
170
.
C. Beylot. (2009) Les différentes toxines botuliques et leurs spécificités. Annales de Dermatologie et de Vénéréologie 136, pages S77-S85.
Crossref
Crossref